Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Nurse Practitioner
Nurse Practitioner Nurse Practitioner

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest

Loading Events...

Study Shows Flu Vaccine Safe For Those With Autoimmune Neuromuscular Disorders | NEWS-Line for Nurse Practitioner

Study Shows Flu Vaccine Safe For Those With Autoimmune Neuromuscular Disorders


Source:

A recent study published in Muscle & Nerve appears to show that the influenza vaccination is safe to use for those with autoimmune neuromuscular disorders.

The study, titled “INFLUENZA VACCINATION OF PATIENTS WITH AUTOIMMUNE NEUROMUSCULAR DISORDERS: A WEB- BASED SURVEY OF CURRENT PRACTICES AND PERCEPTIONS”, was conducted by Tess Litchman, Richard Nowak, and Bhaskar Roy of New Haven, CT. They performed a web-based survey among neurologists across the United States to explore current practices regarding the recommendation of flu shot for patients with myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), or Guillain–Barré syndrome (GBS).

The abstract for this study was published in the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Abstract Guide, which was presented at the 2019 AANEM Annual Meeting in Austin, Texas this October.

Litchman was named a Medical Student award recipient, which is bestowed by the AANEM’s American Neuromuscular Foundation. The foundation funds research that helps identify cures and treatments for neuromuscular diseases. Litchman is a member of AANEM through the Training Program Partnership at Yale. The TPP provides free membership to AANEM through any neurology or physiatry medical school program that signs up with the association.

In the study, a total of 6448 MG, 2310 CIDP, and 1907 GBS patients were followed across practice settings. Respondents reported recommending a flu shot either for all or for >50% of patients in 95%, 84%, and 67% of their MG, CIDP, and GBS patients, respectively. Temporal association of disease relapse with flu shot was reported in 1.6%, 4%, and 9% of MG, CIDP, and GBS patients, respectively.

These results provided the conclusion that “Influenza vaccination was perceived to be safe in the majority of patients with autoimmune neuromuscular disorders.

Neurologists appeared to be more conservative in recommending immunization for patients with a history of GBS. Temporally associated disease relapses appeared to be a risk factor for relapse with subsequent immunization.

To view the 2019 AANEM Abstract Guide, visit https://www.aanem.org/AANEMNew/media/AANEM/Documents/Meetings/2019-Abstracts.pdf.

Source:American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

Photo Credit:Pixbay






Share This!



Loading Jobs...
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.